The Protein Quality Control Machinery Regulates Its Misassembled Proteasome Subunits
The accumulation of misfolded proteins threatens cell fitness and viability and their aggregation is commonly associated with numerous neurodegenerative disorders. Cells therefore rely on a number of protein quality control (PQC) pathways to prevent protein aggregation. In eukaryotes, the ubiquitin proteasome system (UPS), a supramolecular machinery that mediates the proteolysis of damaged or misfolded proteins, plays a vital role in PQC by selectively targeting proteins for degradation. Although the critical role-played by the UPS in PQC, and the severe consequences of impairing this pathway are well established, little was known about the mechanisms that control dysfunctional proteasome subunits. Here, we reveal that the interplay between UPS mediated degradation of its own misassembled subunits, and sorting them into cytoprotective compartments, a process that is mediated by the Hsp42 chaperone, determines how proteasome homeostasis is controlled in yeast cells. We believe that the mechanism of proteasome regulation by the PCQ in yeast may serve as a paradigm for understanding how homeostasis of this essential complex is controlled in major chronic neurodegenerative disorders in higher eukaryotes.
Published in the journal:
. PLoS Genet 11(4): e32767. doi:10.1371/journal.pgen.1005178
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pgen.1005178
Summary
The accumulation of misfolded proteins threatens cell fitness and viability and their aggregation is commonly associated with numerous neurodegenerative disorders. Cells therefore rely on a number of protein quality control (PQC) pathways to prevent protein aggregation. In eukaryotes, the ubiquitin proteasome system (UPS), a supramolecular machinery that mediates the proteolysis of damaged or misfolded proteins, plays a vital role in PQC by selectively targeting proteins for degradation. Although the critical role-played by the UPS in PQC, and the severe consequences of impairing this pathway are well established, little was known about the mechanisms that control dysfunctional proteasome subunits. Here, we reveal that the interplay between UPS mediated degradation of its own misassembled subunits, and sorting them into cytoprotective compartments, a process that is mediated by the Hsp42 chaperone, determines how proteasome homeostasis is controlled in yeast cells. We believe that the mechanism of proteasome regulation by the PCQ in yeast may serve as a paradigm for understanding how homeostasis of this essential complex is controlled in major chronic neurodegenerative disorders in higher eukaryotes.
Introduction
Protein homeostasis encompasses the systems required by the cell for generating and maintaining the correct levels, conformational states, distribution, and degradation of its proteome. Maintaining protein homeostasis is crucial to cells given the toxic potential of misfolded proteins and aggregates. Cells therefore rely on a number of protein quality control (PQC) pathways that survey proteins both during and after synthesis to prevent protein aggregation, promote correct protein folding, and target terminally misfolded proteins to degradation. In eukaryotes, the ubiquitin proteasome system (UPS) plays a vital role in PQC by selectively targeting proteins for degradation [1–4].
The eukaryotic 26S proteasome is a highly conserved 2.5-MD multisubunit protease responsible for degrading a large fraction of intracellular proteins. The 26S proteasome comprises a 20S core particle (CP) and two 19S regulatory particles (RP) that are further divided into lid and base complexes [5]. The degradation of most proteins is mediated by polyubiquitin chains labeling, which leads to their recognition by the 26S proteasome [6]. A diverse array of fundamental biological processes are controlled by the UPS, including cell cycle progression, DNA repair, signal transduction, and PQC in which the cell removes abnormal and toxic proteins generated as a result of environmental damage [7,8]. Under such conditions, chaperones are tasked with accompanying terminally misfolded and aggregated proteins to disposal, or to limit inclusion of these proteins, thereby preventing protein aggregates from causing cell toxicity and from being transferred to the next generation [2]. This chaperone mechanism, alongside the UPS, is termed spatial quality control, and consists of the juxtanuclear quality control compartment (JUNQ) and the insoluble protein deposit (IPOD), which were identified in yeast [9,10]. The JUNQ provides a specialized environment for chaperone-mediated refolding or proteasomal protein degradation. Proteins that are not refolded or degraded in the JUNQ are mobilized to the IPOD.
Alongside its PQC role, the UPS plays an essential role in regulating the degradation and function of nuclear proteins [11–13]. Accordingly, immune-electron microscopy experiments [14] and fluorescent microscopy of GFP-tagged proteasome subunits [15] have established that the 26S proteasome is highly enriched in the nucleus. In exponentially growing yeast cells, 80% of the 26S proteasomes are localized inside the nucleus throughout the cell cycle [16]. Given the importance of the UPS, proteasomal nuclear mislocalization may have severe consequences, for example, a deleterious effect on DNA double strand break repair [13].
Although ubiquitin-mediated proteasomal degradation of many proteins plays a key role in the PQC system, the proteasome itself can become dysfunctional as a result of transcriptional and translational failures, genomic mutations, or diverse stress conditions, leading to misfolded proteins existing in every compartment of the cell. The regulatory pathways, and the identity of the cellular machinery that mediates the sorting sequestration and elimination of dysfunctional proteasomal subunits remain poorly understood.
By using a mutated proteasome lid subunit (termed rpn5ΔC), we show that the nuclear mislocalization, and the cytosolic aggregates formed by this mutant represent a misassembled proteasome lid. With this experimental tool in hand, we were able to demonstrate how the dysfunctional proteasome is controlled by the PQC machinery. We found that among the multilayered quality control mechanisms, the UPS-mediated degradation of its own dysfunctional subunits is the favored pathway. However, in the absence of a functional proteasome, peripheral aggregates that represent misassembled proteasome accumulate in the IPOD, a process that is mediated by the Hsp42 chaperone. We further demonstrate that while the proteasome structure can tolerate the structural defects of the rpn5ΔC mutant and assemble into a functional proteasome, the PQC machinery takes-over, and the mutated protein is spatially removed by the PQC machinery, leading to proteasome dysfunction. Overall, our results demonstrate that proteasome homeostasis is controlled through cellular probing of the quality of proteasome aggregates, and the interplay between UPS-mediated degradation of dysfunctional subunits and alternatively, their accumulation in cytoprotective compartments.
Results/Discussion
The nuclear mislocalization of the C-terminal domain truncated Rpn5 results in proteasomal lid misassembly
Recently, we screened a collection of temperature sensitive (Ts) mutants in the yeast Saccharomyces cerevisiae for those that show a chromosomal instability (CIN) phenotype [17]. This screen identified proteasome subunit genes, such as the Ts allele of the regulatory particle (RP) subunit RPN5, and the core particle (CP) subunit PUP2. The Ts allele of RPN5 was generated by random mutagenesis [17]. Sequence analysis of this mutant revealed that a single base pair insertion resulted in a premature stop codon, leading to a 34 amino acid (aa) truncation at the C-terminal domain (CTD) of Rpn5 (termed rpn5ΔC). To examine the subcellular localization of Rpn5ΔC, GFP was fused at its N-terminus. An identical N-terminal GFP fusion was constructed for the wt RPN5 gene, which was used as a control (both fusion proteins were expressed from a galactose-inducible promoter (GAL1)). RPN5 is an essential gene, and therefore, growth on a glucose-containing medium (which shuts-off the expression of both GAL1-GFP-RPN5 (GFP-RPN5), and GAL1-GFP-rpn5ΔC (GFP-rpn5ΔC)) resulted in cell death (Fig 1Ai-top). In contrast, when the expression of the wt and the truncated gene were induced by growing the cells on 2% galactose, the growth was fully restored at the semi-permissive temperature (30°C) (Fig 1Ai-bottom). Furthermore, as shown in Fig 1Aii-top, similarly to the wt proteasome, the control GFP-Rpn5 protein localized predominantly to the nucleus in logarithmically growing cells. These results indicate that GAL1-GFP-RPN5 fully supports the proteasome function. In contrast, while GFP-Rpn5ΔC cells could still grow at the semi-permissive temperature (30°C), the GFP-Rpn5ΔC protein were detected in cytosolic inclusions in 81% of the cells (n>200) (Fig 1Aii, bottom, other localization patterns are shown in S2A Fig).
Next, we wanted to determine whether the mislocalization caused by rpn5ΔC could be attributed to a failure in proteasome assembly. Previous studies have suggested a model whereby the two parts of the 26S proteasome, namely the CP and RP, are formed and imported to the nucleus independently of each other [18,19]. Our results are in agreement of this model and show that rpn5ΔC leads to the specific mislocalization of another proteasomal lid subunit (Rpn11) (S1Ai and S1Aii Fig), while the core subunits are retained in the nucleus (S1Aiii and S1Aiv Fig). Similar results were obtained in a reciprocal experiment in which the Ts mutant of the CP pup2 affects the nuclear enrichment of Pre6-GFP (another CP), while the RP Rpn11-GFP is unaffected (S1B Fig). To further demonstrate the importance of an intact CTD for proteasome integrity, we generated diploid cells in which the original truncation of 34 aa from the CTD was extended to 45 aa (rpn5Δ45). In this case, no viable haploid rpn5Δ45 spores could be obtained following tetrad dissection (Fig 1B). Moreover, a cross-species complementation experiment revealed that the expression in yeast of a full-length human homolog of RPN5, PSMD12, but not psmd12ΔC, was able to rescue the temperature sensitivity of the rpn5ΔC strain (Fig 1C).
Next, we wished to test the interaction of truncated RPN5 with other proteasomal lid subunits. To this end, we used the protein fragment complementation assay (PCA) [20] to examine the interaction between Rpn5ΔC and several other proteasomal lid subunits (Rpn3, Rpn6, Rpn7, Rpn8, Rpn11, and Rpn12) that were previously shown to interact with Rpn5 [7,21,22]. In this assay (for details see S1C Fig) the interaction between two proteins of interest can be detected by cell growth on media in the presence of the dihydrofolate reductase (DHFR) enzyme inhibitor, methotrexate (MTX). The results show that Rpn5ΔC fails to exhibit the expected interactions when compared to the wt Rpn5 control at the semi-pemissive temperature (Fig 1D).
This result was supported biochemically by an immunoprecipitation experiment showing that when Rpn8 fused to a FLAG-Tag (Rpn8-Flag) is pulled-down, it shows a decreased interaction with Rpn5 containing a 34 aa deletion in its CTD (Rpn5ΔC-F[3]) (S1D Fig).
By generating a series of strains with defined deletions at the C-terminus of Rpn5 (Fig 1D and 1E), we next showed that the interaction with other proteasomal lid subunits is impaired only when the deletion at the CTD domain is greater than 20aa. The physiological importance of these interactions is highlighted by the clear correlation between the extent of truncation and cell viability at the restrictive temperature (34°C) (Fig 1F).
Moreover, we analyzed total protein by immunoblotting with anti Ub Abs. The results (Fig 1G) show a clear increase in protein ubiquitination in GFP-Rpn5ΔC cells, when compared to the GFP-Rpn5 control, at the restrictive temperature of 34°C. We therefore concluded that the presence of the truncated form of RPN5 is associated with proteasome dysfunction.
Our results are in agreement with a previous study showing that in rpn5-1 cells, containing a different CTD-truncated Ts mutant of RPN5, lid subcomplexes are not assembled, even to a partial extent, at the restrictive temperature [18]. This study also specifically examined the effect of the rpn5-1 mutation on the UPS, by evaluating the stability of three model substrates of the ubiquitin–proteasome pathway. The results demonstrated that compared with the wild-type cells, rpn5-1 cells maintained the normally short-lived substrates at a higher level at the semi-permissive temperature, indicating that the rpn5-1 mutation caused a defect in the UPS. [18]. Additional studies mapped the interaction between the subunits of the RP by electron microscopy, tandem mass-spectrometry, affinity purification analysis, and other methods [7,21,23]. These approaches demonstrate that Rpn5, Rpn8, Rpn9, and Rpn11 form a stable soluble subcomplex, and the authors have proposed a subunit interaction map, supporting the notion that Rpn5 is a core component in the lid formation. Furthermore, it was also shown that in yeast, Rpn5 is independently incorporated through its CTD into the proteasomal lid [24].
These results, together with our observation that the RP subunit Rpn11-RFP co-localizes with 98% of the cells containing a large GFP-Rpn5ΔC cytosolic aggregate (n>100) (Fig 2A), suggest that these aggregates represent misassembled proteasome lid intermediates.
Inhibition of 26S proteasome assembly in rpn5ΔC mutants
Next, we tested the degree of lid assembly into 26S proteasome holocomplexes in GFP-Rpn5, or GFP-Rpn5ΔC at the semi-permissive and restrictive temperatures using the in-gel peptidase activity assay. In this assay proteasomes are resolved by non-denaturing PAGE according to their charge/mass ratio directly from whole cell extract, and visualized based on inherent peptidase activity as described in [25]. The results (Fig 2B) clearly show that similarly to cells expressing the endogenous levels of Rpn5 in the wt, the over-expression of GFP-Rpn5 by a galactose inducible promoter, had no effect on proteasome integrity, as in both cases similar amounts of proteasomes were found as a mixture of RP2CP, and RP1CP. In contrast, the over production of GFP-Rpn5ΔC resulted in structural defects, as evident by higher levels of RP1CP at the semi permissive temperature (30°C), and free BaseCP and CP mostly at the restrictive temperature (34°C). Similar defects were previously reported by Yu et al, when using rpn5ΔC mutant, expressed through its endogenous promoter [24]. Taken together, these results clearly show that proteasome assembly is inhibited in rpn5ΔC cells, and that the misassembled lid in rpn5ΔC is not associated with active proteasome.
Misassembled proteasome subunits co-localize with the insoluble protein deposit (IPOD) compartment
Aggregation prone proteins are partitioned between the JUNQ and the IPOD [9,10,26]. Proteins that are ubiquitinated by the PQC machinery are delivered to the JUNQ where they are processed for degradation by the proteasome [9]. We therefore hypothesized that the impairment of the PQC degradation pathway by the rpn5ΔC mutant, should lead to the accumulation of misassembled proteasomal lid subunits in the IPOD. To test this idea, we followed the localization of Hsp104, a commonly used IPOD marker [9,10,27], fused to TFP (Hsp104-TFP), in a GFP-Rpn5ΔC strain grown in rich galactose containing medium. Our results show that in all cases where GFP-Rpn5ΔC cytosolic inclusions could be detected (81% of the cells, n>200, S2A Fig), the largest inclusion always co-localized with Hsp104-TFP (n>200) (Fig 2C). Similar results were obtained with the glutamine-rich prion protein Rnq1 fused to mCherry (Rnq1-mCherry), another well-established IPOD marker (Fig 2D) [9,10,27]. Taken together, these findings suggest that peripheral foci containing misassembled Rpn5ΔC are directed to the IPOD when a functional proteasome is scarce, such as in rpn5ΔC cells.
It should be noted that since the RPN5 proteasome subunit is essential for cell viability [17,28], our experiments were performed mainly at the semi-permissive temperature (30°C), to enable its partial (hypomorphic) function. At this temperature, some proteasomes apparently function sufficiently to support cell growth. Indeed, in 19% of the cells (n>200), the GFP-Rpn5ΔC signal was limited to the nucleus, the expected localization in proliferating cells (S2A-top Fig). Since the sequestration of aggregates to the IPOD was shown to preclude their delivery by the parental cells to subsequent generations [10], the nuclear GFP-Rpn5ΔC signal, may also represent the functional proteasomes in recently separated daughter cells, as demonstrated in S1 Movie. This idea is also supported by calcofluor staining showing that the GFP-Rpn5ΔC signal was not detected as cytosolic inclusions in 98% of the daughter cells issued from IPOD containing mother cells (Fig 2E).
In addition to the nuclear localization, 81% of cells showed cytosolic inclusions of the GFP-Rpn5ΔC signal with the following patterns (representative images are shown in S2A Fig, n>200): 25% exhibited a single large cytosolic aggregate representing the IPOD, and 39% contained a second smaller juxtanuclear protesomal signal, likely representing the JUNQ [9]. Finally, it was recently demonstrated that under acute stress (such as in the case of partially assembled proteasome), misfolded proteins are initially collected and processed in the form of multiple puncta named Q-bodies, which are rapidly reversible structures, that can be dynamically directed to folding and refolding by the chaperone machinery, or to degradation by the proteasome or autophagy system [10,26]. Indeed in 17% of the cells, we detected many cytosolic aggregated bodies, which probably represent these structures.
The ubiquitin proteasome system mediates the degradation of misassembled proteasomal subunits
One of the challenges faced by the cell in maintaining protein homeostasis is the presence of misfolded proteins. The UPS, in particular, plays a critical role in PQC by selectively targeting proteins for degradation. To test whether the UPS can also regulate the degradation of its own misassembled subunits, we introduced a functional allele of RPN5 by mating the haploid GFP-rpn5ΔC strain to another haploid containing a wt copy of RPN5. The complementation of GFP-rpn5ΔC by RPN5 was indicated by the restoration of growth at the restrictive temperature, and the nuclear localization of the Rpn5 wt protein (Rpn5-RFP) (Fig 3A and 3B). Similarly Rpn11-GFP also localized to the nucleus in rpn5ΔC/RPN5 cells (S2B Fig when compared to rpn5ΔC haploids (Fig 2A). Interestingly, in the presence of a functional copy of RPN5, the GFP-Rpn5ΔC puncta was no longer detected in 97% of the cells (n>100) (Fig 3C). Furthermore, the addition of the proteasome inhibitor, MG132, stabilized the GFP-Rpn5ΔC signal, and led to its reproducible accumulation in the IPOD in 68% of the cells (n>100), compared to the DMSO control (Fig 3D). The accumulation of GFP-Rpn5ΔC in cells treated with MG132 was further confirmed by GAL promoter shutoff experiments followed by Western Blot analysis (S2C Fig).
Previous studies suggested that the ubiquitination level of a protein determines whether it is sequestered into the IPOD or JUNQ compartments [9,29]. Impairing misfolded protein ubiquitination blocked their accumulation in the JUNQ, and instead resulted in excessive accumulation in the IPOD [9]. The UPS-mediated degradation of Rpn5ΔC in heterozygote diploids (containing a wt copy of RPN5), suggests that Rpn5ΔC is in a ubiquitinated form, when localized to the IPOD. In order to explain this discrepancy, we propose that in rpn5ΔC haploids, the cells are under constant acute stress, due to proteasome impairment. Under such conditions, the degradation mechanism is blocked, and therefore there is no alternative, aside from targeting the misassembled lid to the IPOD. This idea is supported by previous reports that proteasome inhibition leads to the accumulation of substrates that are normally degraded by the UPS (such as Ubc9ts) into the JUNQ and IPOD [9,26]. In conjunction with this, other studies have demonstrated that when the degradation capacity of the JUNQ declines, with JUNQ-localized proteasomes becoming inactive, a protective alternative is furnished by the IPOD, and toxic aggregating species are rerouted from the JUNQ to the IPOD [30]. We therefore suggest that in our case, when cells fail to degrade misassembled proteasome lid subunits, they can be targeted to the IPOD when still conjugated to ubiquitin.
Taken together, our results suggest that the preferred PQC pathway of misassembled proteasome subunits is degradation by the UPS. As functional proteasomes are scarce in rpn5ΔC cells grown at the restrictive temperature, the UPS pathway is hindered. Thus, misassembled lid subunits are ultimately diverted to the IPOD.
HSP42-dependent sequestration of misassembled proteasomal lid subunits precludes the assembly of functional proteasomes
Molecular chaperones prevent aggregation and misfolding of proteins, and are thus central to maintaining protein homeostasis. Two chaperones that were previously shown to mediate spatial sequestration of misfolded proteins are the small heat shock proteins Hsp26 and Hsp42. These chaperones efficiently co-aggregate with misfolded proteins, thereby altering the properties of protein aggregates and facilitating disaggregation by other chaperones [31]. This process is a key molecular event that determines whether such a protein is sorted to the JUNQ or to a peripheral site [32,33]. As shown in Fig 4A and 4B, both Hsp26 and Hsp42, fused to TFP, colocalized with GFP-Rpn5ΔC in 100% of the cells containing a large cytosolic aggregate, representing the IPOD (n>200). Similar results were obtained when we investigated the co-localization of Hsp42-TFP with Rpn11-GFP on a rpn5ΔC background expressed from its endogenous promoter (Fig 4C). Since we have shown that Rpn5ΔC co-localizes with Rpn11 (Fig 2A), and that Hsp42 co-localizes with the IPOD marker Hsp104 on a rpn5Δc background in 95% of the cells (n>200) (Fig 4D), we conclude that Hsp42 colocalizes with the misassembled proteasome lid in the IPOD. This co-localization is probably associated with physical interactions between Hsp42 and misassembled proteasome subunits, as indicated by the co-immunoprecipitation between the lid subunit Rpn8, and Hsp42 in rpn5ΔC cells (S2D Fig).
Given the role of HSP42, HSP26 and HSP104 in controlling the sequestration of protein aggregates into deposition sites [32–34], we hypothesized that the sequestration of GFP-Rpn5ΔC to the IPOD may also depend on these chaperones. To investigate this possibility, we examined the localization of GFP-Rpn5ΔC in Δhsp42, Δhsp26 and Δhsp104 cells. In contrast to Δhsp26, and Δhsp104 which only had a minor effect on GFP-Rpn5ΔC cytosolic peripheral focus (S2E and S2F Fig), in cells lacking HSP42, the GFP-Rpn5ΔC signal was no longer observed in the cytosolic periphery. Instead, it showed the nuclear enrichment expected of the wt proteasome (Fig 4E-bottom). Similar results were obtained with Rpn11-GFP in a strain mutated in both HSP42 and RPN5 (Δhsp42, rpn5Δc) (Fig 4F-bottom). We therefore concluded that association of misassembled proteasome lid subunits with Hsp42 is required for their accumulation in the IPOD. Strikingly, while the deletion of HSP26, and HSP104 had no effect, the nuclear relocalization of GFP-Rpn5ΔC in Δhsp42 cells was clearly associated with increased survival at 34°C (Fig 4G), and as revealed by the in gel peptidase activity assay, with the reassembly of functional proteasomes (Fig 4H). Taken together, these results show that HSP42 plays an essential role in mediating the sequestration of misassembled proteasome lid subunits to the IPOD.
Our data is in agreement with previous studies that mapped the interactions between subunits of the proteasome regulatory particles, and led to the notion that Rpn5 is a core component in lid formation [7,21,23], and that in yeast, Rpn5 is independently incorporated through its CTD into the proteasomal lid [24]. Our model (Fig 5) suggests that there is competition between assembly, degradation and aggregation of proteasome subunits. The employment of rpn5ΔC shifts the balance, since this mutation partially impairs proteasome lid assembly, which in contrast to wt RPN5, triggers the activation of the PQC machinery. At the restrictive temperature, the lid is mostly misassembled, and the degradation pathway is blocked, which results in the independent recruitment of Rpn5ΔC, and other lid subunits to the IPOD in an HSP42 dependent manner. This slower assembly has a dual effect: It increases the amount of the unassembled subunits, and at the same time decreases its degradation, because there is less proteasomes available. Hence, the misassembled subunits aggregate in the IPOD.
The fact that the deletion of HSP42 restores cell growth at 34°C, suggests that at this temperature, cells can still tolerate the CTD truncation in Rpn5, and assemble partially functional proteasomes (Fig 4G and 4H). A previous study supports this idea by proteasome fractionation using a glycerol gradient, showing that although the truncation influenced integration of additional subunits, Rpn5ΔC could still integrate into the proteasome at the semi-permissive temperature [8]. However, the cell stress imposed by partial misassembly of the lid in the rpn5 mutant activates the PQC machinery. This activation causes further damage, since lid subunits are independently removed to the IPOD by Hsp42, which in turn leads to complete lid misassembly, proteasome dysfunction, and cell death at the restrictive temperature (34°C). In agreement with this model, the omission of HSP42 probably prevents the rapid sequestration of Rpn5ΔC into aggregates, allowing more time for 26S proteasomes to assemble, and to degrade the unassembled lid subunits.
Thus, while it was believed that the Rpn5ΔC mutation causes purely structural defects [18], our study provides a plausible alternative mechanism. We suggest that spatial separation of misassembled proteasome lid subunits mediated by the PQC machinery is the key pathway leading to proteasome dysfunction, rather than the structural defects within the RPN5 mutant.
Taken together, our results reveal that proteins harboring mutations that activate the PQC can be eliminated from the cells, even when the protein is still functional, and the damage ensuing from diverting essential protein products. In light of this, cells have adopted numerous PQC pathways to aid folding, mediate degradation, or to accumulate such proteins in stress foci [3]. This idea is nicely demonstrated by the ΔF508 mutation within the fibrosis transmembrane conductance regulator (CFTR), highly associated with cystic fibrosis (CF) [35]. Although the mutated protein retains significant chloride-channel function, the protein is rapidly recognized by the PQC machinery and is degraded shortly after synthesis, before it can reach its site of activity at the cell surface [36].
Concluding remarks
Although the critical role-played by the UPS in PQC, and the severe consequences of impairing this pathway are well established, little was known about the mechanisms that control dysfunctional proteasome subunits. Our results demonstrate for the first time that proteasome homeostasis is controlled through the interplay between UPS mediated degradation of its misassembled subunits, and sorting into the IPOD, a process that is mediated by the Hsp42 chaperone, which determines how proteasome homeostasis is controlled in yeast cells.
The assembly of the proteasome is an intricate process due to the number of subunits that must associate to form an active complex. We used a synthetic mutant that induces proteasome dysfunction. However, the UPS function can be naturally impaired by many factors, including mutations, errors during transcription, RNA processing and translation, trapping of a folding intermediate, incorrect incorporation into multimeric complexes or oxidative damage, all of which are processes that are accelerated during aging [37]. Dysregulation of this pathway results in intracellular deposits of ubiquitin protein conjugates which can be seen in age-related pathologies and in all the major chronic neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Huntington’s diseases as well as amyotrophic lateral sclerosis (ALS) and others [37] [38].
The mechanism of proteasome regulation by the PQC in yeast may serve as a paradigm to understand how homeostasis of this essential complex is controlled in higher eukaryotes. Identifying additional chaperones that work in conjunction with Hsp42, and elucidating the identity of the structurally abnormal features that the PQC machinery recognizes in the misassembled proteasome, will provide further insight into the recognition and targeting mechanisms of dysfunctional proteasomes in cells.
Materials and Methods
Yeast strains, plasmids, and growth conditions
Unless otherwise stated, all the strains used in this study are isogenic to BY4741, BY4742, or BY4743 [39]. The relevant genotypes are presented in S1 Table. Deletions, GFP, TFP, and mCherry fusions were generated using one step PCR mediated homologous recombination as previously described [40,41]. For all deletions, the selection markers replaced the coding region of the targeted genes. GFP, TFP and mCherry were fused at the 3’ end of the coding region of the targeted genes, by replacement of their stop codons [40,41]. A GAL1 promoter was placed at the N-terminal of RPN5 and RPN5ΔC by replacement of their start codon. We have shown that the expression of the fusion protein GAL1-GFP-RPN5 has no effect on proteasome normal phenotype (Fig 1A). Strains containing different mDHFR-F[1,2], and mDHFR-F[3] C-terminal fusion proteins were obtained from the PCA collection (commercially available from Open Biosystems), or in cases in which the strains were absent from the collection, by one step PCR mediated homologous recombination, as described by Tarassov, K, et al. [20]. For C-terminal truncations by mDHFR-F3 (Fig 2D and 2E), this fragment was targeted to replace the truncated amino acids at the 3’ end.
Plasmids
The plasmids used to express PSMD12, the human homolog of RPN5 were generated using the Gateway Technology (available from Invitrogen). Human cDNA of PSMD12 (Open Biosystems Cat#BC019062) was used as a template for the PCR reactions. PCR products were first cloned into pDONR221 (Invitrogen cat# 12536–017) using the BP recombination reaction (see Invitrogen manual). The LR recombination reaction was then used for cloning into the pYES-DEST52 destination vector (cat#12286019), for expressing PSMD12 or PSMD12ΔC under the control of the GAL1 promoter in yeast. The pESC::GAL1-RNQ1-mCherry, LEU2 marked plasmid was a kind gift from D. Kaganovich’s laboratory (The Hebrew University, Jerusalem, Israel) [9].
Growth conditions
Yeast cells were grown in synthetic complete medium (SC; 0.17% yeast nitrogen base, 0.5% (NH4)2SO4, and amino acids), supplemented with either 2% glucose (SD), or galactose (SC-GAL). Unless otherwise stated, cells were grown at 30°C. As described previously [42,43], for logarithmic culture, cells were grown for 16–18 h and then back diluted 10x with fresh media and allowed to grow for 2 hrs. Proteasomes were inhibited by adding 20μM of the proteasome inhibitor MG132 (prepared from an 800μM MG132 in DMSO stock solution, Sigma), in strains deleted in the ERG6 gene, to prevent the cells from pumping the drug out of the cell. Standard YEP medium (1% yeast extract, 2% Bacto Peptone) supplemented with, 2% galactose (YP-GAL), or 2% dextrose (YPD) was used for nonselective growth. 2% Bacto Agar was added for solid media.
Microscopy
Microscopy was performed as previously described [42]. Briefly, cells were observed in a fully automated inverted microscope (Zeiss observer. Z1 Carl Zeiss, Inc.) equipped with an MS-2000 stage (Applied Scientific Instrumentation), a Lambda DG-4 LS 300 W xenon light source (Sutter Instrument), a 63x Oil 1.4 NA Plan-Apochromat objective lens, and a six-position filter cube turret with a GFP filter (excitation, BP470/40; emission, BP525/50; Beamsplitter, FT495), a HcRed filter (excitation, BP592/24; emission, BP675/100; Beamsplitter, FT615), and a DAPI filter (excitation, G365; emission, BP445/50; Beamsplitter, FT395) from Chroma Technology Corp. Images were acquired using a CoolSnap HQ2 camera (Roper Scientific). The microscope, camera and shutters (Uniblitz) were controlled by AxioVision Rel. 4.8.2. Images are a single plane of z-stacks performed using a 0.5 μm step.
PCA assay
The PCA was performed as described previously [20]. Strains were mated on YPD, and diploids were selected on YPD supplemented with clonNAT and hygB. SD supplemented with noble agar (Difco), and methotrexate (MTX; Bioshop Canada) was used for the final selection steps. Drugs were added to the following final concentrations: clonNAT (100 μg/ml, Werner Bioagents); MTX (200 μg/ml (prepared from a 10 mg/ml methotrexate in DMSO stock solution, Bioshop Canada); and HygromycinB (100 μg/ml, Calbiochem).
Co-immunoprecipitations and western blot analysis
Co-immunoprecipitations and Western blot analysis were carried out as described previously [43]. The antibodies used for the Western blot analysis were anti-DHFR-[F3] (Sigma), anti-FLAG (Sigma), anti-Ubiquitin (Dako Dk-z045801-2), anti-GFP (Roche 11–814460001).
Native-PAGE
Cultures were grown overnight and washed twice with DDW and once with chilled buffer A (25 mM Tris [pH 7.4], 10 mM MgCl2, 10% glycerol, 1 mM ATP, and 1 mM dithiothreitol [DTT]). Pellet was resuspended in two volumes of buffer A and lysed using glass beads at 4°C. Native lysates were clarified by centrifugation at 16,000×g for 15 min.
Peptidase activity
Proteasome peptidase activity was studied in native PAGE using the substrate succinyl-LLVY-7-amido-4-methylcoumarinfluorescent peptide (Bachem, Bubendorf, Switzerland) as previously published [24,25].
Supporting Information
Zdroje
1. Su H, Wang X (2010) The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc Res 85: 253–262. doi: 10.1093/cvr/cvp287 19696071
2. Kastle M, Grune T (2012) Interactions of the proteasomal system with chaperones: protein triage and protein quality control. Prog Mol Biol Transl Sci 109: 113–160. doi: 10.1016/B978-0-12-397863-9.00004-3 22727421
3. Comyn SA, Chan GT, Mayor T (2014) False start: Cotranslational protein ubiquitination and cytosolic protein quality control. J Proteomics 100C: 92–101.
4. Amm I, Sommer T, Wolf DH (2014) Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system. Biochim Biophys Acta 1843: 182–196. doi: 10.1016/j.bbamcr.2013.06.031 23850760
5. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425–479. 9759494
6. Tanaka K (2009) The proteasome: overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci 85: 12–36. 19145068
7. Fukunaga K, Kudo T, Toh-e A, Tanaka K, Saeki Y (2010) Dissection of the assembly pathway of the proteasome lid in Saccharomyces cerevisiae. Biochem Biophys Res Commun 396: 1048–1053. doi: 10.1016/j.bbrc.2010.05.061 20471955
8. Ciechanover A (2005) Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ 12: 1178–1190. 16094394
9. Kaganovich D, Kopito R, Frydman J (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454: 1088–1095. doi: 10.1038/nature07195 18756251
10. Spokoini R, Moldavski O, Nahmias Y, England JL, Schuldiner M, et al. (2012) Confinement to organelle-associated inclusion structures mediates asymmetric inheritance of aggregated protein in budding yeast. Cell Rep 2: 738–747. doi: 10.1016/j.celrep.2012.08.024 23022486
11. Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164–171. 12648672
12. Nasmyth K (2002) Segregating sister genomes: the molecular biology of chromosome separation. Science 297: 559–565. 12142526
13. Ben-Aroya S, Agmon N, Yuen K, Kwok T, McManus K, et al. (2010) Proteasome nuclear activity affects chromosome stability by controlling the turnover of Mms22, a protein important for DNA repair. PLoS Genet 6: e1000852. doi: 10.1371/journal.pgen.1000852 20174551
14. Wilkinson CR, Wallace M, Morphew M, Perry P, Allshire R, et al. (1998) Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J 17: 6465–6476. 9822592
15. Enenkel C, Lehmann A, Kloetzel PM (1999) GFP-labelling of 26S proteasomes in living yeast: insight into proteasomal functions at the nuclear envelope/rough ER. Mol Biol Rep 26: 131–135. 10363659
16. Russell SJ, Steger KA, Johnston SA (1999) Subcellular localization, stoichiometry, and protein levels of 26 S proteasome subunits in yeast. J Biol Chem 274: 21943–21952. 10419517
17. Ben-Aroya S, Coombes C, Kwok T, O'Donnell KA, Boeke JD, et al. (2008) Toward a comprehensive temperature-sensitive mutant repository of the essential genes of Saccharomyces cerevisiae. Mol Cell 30: 248–258. doi: 10.1016/j.molcel.2008.02.021 18439903
18. Isono E, Nishihara K, Saeki Y, Yashiroda H, Kamata N, et al. (2007) The assembly pathway of the 19S regulatory particle of the yeast 26S proteasome. Mol Biol Cell 18: 569–580. 17135287
19. Li X, Kusmierczyk AR, Wong P, Emili A, Hochstrasser M (2007) beta-Subunit appendages promote 20S proteasome assembly by overcoming an Ump1-dependent checkpoint. EMBO J 26: 2339–2349. 17431397
20. Tarassov K, Messier V, Landry CR, Radinovic S, Serna Molina MM, et al. (2008) An in vivo map of the yeast protein interactome. Science 320: 1465–1470. doi: 10.1126/science.1153878 18467557
21. Sharon M, Taverner T, Ambroggio XI, Deshaies RJ, Robinson CV (2006) Structural organization of the 19S proteasome lid: insights from MS of intact complexes. PLoS Biol 4: e267. 16869714
22. Sha Z, Yen HC, Scheel H, Suo J, Hofmann K, et al. (2007) Isolation of the Schizosaccharomyces pombe proteasome subunit Rpn7 and a structure-function study of the proteasome-COP9-initiation factor domain. J Biol Chem 282: 32414–32423. 17761670
23. Fu H, Reis N, Lee Y, Glickman MH, Vierstra RD (2001) Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J 20: 7096–7107. 11742986
24. Yu Z, Kleifeld O, Lande-Atir A, Bsoul M, Kleiman M, et al. (2011) Dual function of Rpn5 in two PCI complexes, the 26S proteasome and COP9 signalosome. Mol Biol Cell 22: 911–920. doi: 10.1091/mbc.E10-08-0655 21289098
25. Leggett DS, Glickman MH, Finley D (2005) Purification of proteasomes, proteasome subcomplexes, and proteasome-associated proteins from budding yeast. Methods Mol Biol 301: 57–70. 15917626
26. Escusa-Toret S, Vonk WI, Frydman J (2013) Spatial sequestration of misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during stress. Nat Cell Biol 15: 1231–1243. doi: 10.1038/ncb2838 24036477
27. Hill SM, Hao X, Liu B, Nystrom T (2014) Life-span extension by a metacaspase in the yeast Saccharomyces cerevisiae. Science 344: 1389–1392. doi: 10.1126/science.1252634 24855027
28. Glickman MH, Rubin DM, Fried VA, Finley D (1998) The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol Cell Biol 18: 3149–3162. 9584156
29. Amen T, Kaganovich D (2015) Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and disease. Cell Mol Life Sci 72: 401–415. doi: 10.1007/s00018-014-1740-y 25283146
30. Weisberg SJ, Lyakhovetsky R, Werdiger AC, Gitler AD, Soen Y, et al. (2012) Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc Natl Acad Sci U S A 109: 15811–15816. 22967507
31. Haslbeck M, Miess A, Stromer T, Walter S, Buchner J (2005) Disassembling protein aggregates in the yeast cytosol. The cooperation of Hsp26 with Ssa1 and Hsp104. J Biol Chem 280: 23861–23868. 15843375
32. Specht S, Miller SB, Mogk A, Bukau B (2011) Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. J Cell Biol 195: 617–629. doi: 10.1083/jcb.201106037 22065637
33. Malinovska L, Kroschwald S, Munder MC, Richter D, Alberti S (2012) Molecular chaperones and stress-inducible protein-sorting factors coordinate the spatiotemporal distribution of protein aggregates. Mol Biol Cell 23: 3041–3056. doi: 10.1091/mbc.E12-03-0194 22718905
34. Shiber A, Breuer W, Brandeis M, Ravid T (2013) Ubiquitin conjugation triggers misfolded protein sequestration into quality control foci when Hsp70 chaperone levels are limiting. Mol Biol Cell 24: 2076–2087. doi: 10.1091/mbc.E13-01-0010 23637465
35. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073–1080. 2570460
36. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352: 1992–2001. 15888700
37. Wolfe KJ, Cyr DM (2011) Amyloid in neurodegenerative diseases: friend or foe? Semin Cell Dev Biol 22: 476–481. doi: 10.1016/j.semcdb.2011.03.011 21458579
38. Rott R, Szargel R, Haskin J, Bandopadhyay R, Lees AJ, et al. (2011) alpha-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A 108: 18666–18671. doi: 10.1073/pnas.1105725108 22065755
39. Brachmann CB, Davies A, Cost GJ, Caputo E, Li J, et al. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 115–132. 9483801
40. Goldstein AL, McCusker JH (1999) Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15: 1541–1553. 10514571
41. Longtine MS, McKenzie A, 3rd, Demarini DJ, NG Shah, A Wach, et al. (1998) Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14: 953–961. 9717241
42. Peters LZ, Hazan R, Breker M, Schuldiner M, Ben-Aroya S (2013) Formation and dissociation of proteasome storage granules are regulated by cytosolic pH. J Cell Biol 201: 663–671. doi: 10.1083/jcb.201211146 23690178
43. Lev I, Volpe M, Goor L, Levinton N, Emuna L, et al. (2013) Reverse PCA, a systematic approach for identifying genes important for the physical interaction between protein pairs. PLoS Genet 9: e1003838. doi: 10.1371/journal.pgen.1003838 24130505
44. Park SH, Kukushkin Y, Gupta R, Chen T, Konagai A, et al. (2013) PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 154: 134–145. doi: 10.1016/j.cell.2013.06.003 23791384
Štítky
Genetika Reprodukční medicínaČlánek vyšel v časopise
PLOS Genetics
2015 Číslo 4
Nejčtenější v tomto čísle
- Lack of GDAP1 Induces Neuronal Calcium and Mitochondrial Defects in a Knockout Mouse Model of Charcot-Marie-Tooth Neuropathy
- Proteolysis of Virulence Regulator ToxR Is Associated with Entry of into a Dormant State
- Frameshift Variant Associated with Novel Hoof Specific Phenotype in Connemara Ponies
- Ataxin-2 Regulates Translation in a New BAC-SCA2 Transgenic Mouse Model